Segall Bryant & Hamill LLC Takes Position in Addus HomeCare Corporation (NASDAQ:ADUS)

Segall Bryant & Hamill LLC purchased a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm purchased 16,419 shares of the company's stock, valued at approximately $1,624,000. Segall Bryant & Hamill LLC owned 0.09% of Addus HomeCare at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in ADUS. Capital Research Global Investors purchased a new position in shares of Addus HomeCare in the 4th quarter valued at $51,149,000. American Century Companies Inc. increased its holdings in shares of Addus HomeCare by 695.8% in the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock valued at $35,643,000 after acquiring an additional 248,613 shares during the period. GAMMA Investing LLC grew its stake in Addus HomeCare by 10,307.8% during the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock worth $12,948,000 after buying an additional 129,672 shares during the last quarter. Bank of America Corp DE grew its stake in Addus HomeCare by 273.6% during the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock worth $21,945,000 after buying an additional 128,211 shares during the last quarter. Finally, Principal Financial Group Inc. grew its stake in Addus HomeCare by 18.3% during the 1st quarter. Principal Financial Group Inc. now owns 475,818 shares of the company's stock worth $47,054,000 after buying an additional 73,720 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ADUS has been the topic of several research analyst reports. JMP Securities restated a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research note on Wednesday. Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. Finally, Macquarie restated an "outperform" rating and set a $133.00 target price on shares of Addus HomeCare in a research note on Tuesday, June 10th. Seven equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Addus HomeCare has an average rating of "Buy" and an average target price of $142.57.

Addus HomeCare Stock Performance

ADUS traded down $2.66 on Friday, reaching $107.03. 136,336 shares of the stock were exchanged, compared to its average volume of 166,386. The company's 50-day moving average price is $112.44 and its 200 day moving average price is $109.91. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a market capitalization of $1.97 billion, a PE ratio of 24.16, a PEG ratio of 1.52 and a beta of 0.81.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The company had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. During the same quarter in the previous year, the firm posted $1.21 EPS. The firm's revenue was up 20.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.

Insider Activity

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the transaction, the executive vice president owned 7,796 shares of the company's stock, valued at $896,540. The trade was a 20.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 4.60% of the stock is currently owned by company insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.